SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 941 | 2022 |
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 681 | 2021 |
Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis S Sze, D Pan, CR Nevill, LJ Gray, CA Martin, J Nazareth, JS Minhas, ... EClinicalMedicine 29, 2020 | 653 | 2020 |
The impact of ethnicity on clinical outcomes in COVID-19: a systematic review D Pan, S Sze, JS Minhas, MN Bangash, N Pareek, P Divall, CML Williams, ... EClinicalMedicine 23, 2020 | 570 | 2020 |
Ethnicity and COVID-19: an urgent public health research priority M Pareek, MN Bangash, N Pareek, D Pan, S Sze, JS Minhas, W Hanif, ... The Lancet 395 (10234), 1421-1422, 2020 | 505 | 2020 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 381* | 2021 |
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 317* | 2022 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 227 | 2022 |
Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study CA Martin, DR Jenkins, JS Minhas, LJ Gray, J Tang, C Williams, S Sze, ... EClinicalMedicine 25, 2020 | 156 | 2020 |
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 142 | 2022 |
Awake prone positioning in COVID-19 D Koeckerling, J Barker, NL Mudalige, O Oyefeso, D Pan, M Pareek, ... Thorax 75 (10), 833-834, 2020 | 100 | 2020 |
COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life J Barker, O Oyefeso, D Koeckerling, NL Mudalige, D Pan Thorax, 2020 | 75 | 2020 |
Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance JJ Cuthbert, P Pellicori, A Rigby, D Pan, S Kazmi, P Shah, AL Clark European journal of heart failure 20 (10), 1426-1435, 2018 | 74 | 2018 |
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of … X Liu, APS Munro, S Feng, L Janani, PK Aley, G Babbage, D Baxter, ... Journal of Infection 84 (6), 795-813, 2022 | 60 | 2022 |
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19 CM Williams, D Pan, J Decker, A Wisniewska, E Fletcher, S Sze, S Assadi, ... Journal of Infection 82 (6), 253-259, 2021 | 49 | 2021 |
Acute kidney injury in pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus-2 pandemic: experience from PICUs … A Deep, G Upadhyay, P Du Pré, J Lillie, D Pan, N Mudalige, ... Critical care medicine 48 (12), 1809-1818, 2020 | 48 | 2020 |
Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis CA Martin, D Pan, C Melbourne, L Teece, A Aujayeb, RF Baggaley, ... PLoS Medicine 19 (5), e1004015, 2022 | 43* | 2022 |
Monkeypox in the UK: arguments for a broader case definition D Pan, S Sze, J Nazareth, CA Martin, A Al-Oraibi, RF Baggaley, ... The Lancet 399 (10344), 2345-2346, 2022 | 39 | 2022 |
Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants P Irizar, D Pan, D Kapadia, L Bécares, S Sze, H Taylor, S Amele, ... EClinicalMedicine 57, 2023 | 37 | 2023 |
Is the UK prepared for seasonal influenza in 2022–23 and beyond? J Nazareth, D Pan, CA Martin, I Barr, SG Sullivan, I Stephenson, A Sahota, ... The Lancet Infectious Diseases 22 (9), 1280-1281, 2022 | 33 | 2022 |